GSTM1 and anemia (phenotype): In conclusion, our study shows for the first time that paricalcitol, compared to calcitriol, exerts a beneficial effect on Hb levels in patients with advanced CKD independent of several confounding factors involved in anemia pathogenesis, like inflammation and PTH levels.